AVITA Medical, Inc. (RCEL): Total Liabilities
$73.04M
As of 2025-12-31
$75.61M
As of 2026-06-30
+77.9%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $73.04M | -2.6% | 2026-02-12, Balance as of period end |
| 2024-12-31 | $74.97M | +21.1% | 2026-02-12, Balance as of period end |
| 2023-12-31 | $61.89M | +377.3% | 2025-02-13, Balance as of period end |
| 2022-12-31 | $12.97M | +13.8% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $11.39M | n/a | 2023-02-23, Balance as of period end |
| 2021-06-30 | $9.85M | -2.1% | 2023-02-23, Balance as of period end |
| 2020-06-30 | $10.06M | +103.2% | 2021-08-26, Balance as of period end |
| 2019-06-30 | $4.95M | n/a | 2020-08-27, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $73.04M | -2.6% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $51.36M | -7.2% |
| PRO DEX Inc (PDEX) | 2026-06-30 | $26.88M | +9.4% |
| TELA Bio, Inc. (TELA) | 2025-12-31 | $75.11M | +29.2% |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | 2024-12-31 | $27.26M | +8.7% |
| Iradimed Corp (IRMD) | 2025-12-31 | $14.16M | +23.0% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $12.41M | +58.3% |
| LENSAR, Inc. (LNSR) | 2025-12-31 | $83.67M | +75.6% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $75.17M | -2.4% |
Compare RCEL, SGHT, PDEX, TELA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗